FDA ApprovedUnited States
Heart Pill for Obstructive HCM from About 66 Pounds
Camzyos (mavacamten) — oral treatment for symptomatic obstructive HCM from about 66 lb
US label expanded 9/2026 to patients ≥30 kg including eligible adolescents; SCOUT-HCM NCT06253221; REMS required
This is for families living with symptomatic obstructive hypertrophic cardiomyopathy when the person weighs at least 30 kg (about 66 lb).